Evidence map›Paper›PMID 32226055›Full record

ArticleBulletin de l'Academie nationale de medecine

Brigitte Autran, Béhazine Combadière, Odile Launay, Roger Legrand, Camille Locht, Frédéric Tangy, Pierre Verger, Nathalie Garçon

Abstract readEnglish Abstract
In one paragraph

Article in Bulletin de l'Academie nationale de medecine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brigitte AutranSorbonne Universités, UPMC Univ Paris 06, INSERM, U1135, Centre, d'Immunologie et des Maladies Infectieuses (CIMI-, Paris, UMRS 1135), Paris, F-75013, France.
Béhazine CombadièreSorbonne Universités, UPMC Univ Paris 06, INSERM, U1135, Centre, d'Immunologie et des Maladies Infectieuses (CIMI-, Paris, UMRS 1135), Paris, F-75013, France.
Odile LaunayComité de Pilotage de CoRevac, Institut Thématique Immunité-Infection-Inflammation-Microbiologie, AVIESAN, Paris, France.
Roger LegrandCEA, Université Paris Sud, Inserm U1184, Infrastructure IDMIT, Fontenay-aux-Roses, France.
Camille LochtCentre d'Infection et Immunité de Lille, Institut Pasteur de Lille; Université de Lille; Inserm U1019; CNRS UMR-8204.
Frédéric TangyUnité de Génomique Virale et Vaccination, Institut Pasteur, CNRS UMR-3569.
Pierre VergerORS Paca, UMR SESSTIM, AMU.
Nathalie GarçonBIOASTER IRT, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMMARYThe explosion of vaccines during the 20th century allowed the control of numerous infectious plagues but multiple challenges oppose conservation and extension of these successes. The hesitation of modern societies in front of vaccinations requires researches in life, human and social sciences in order to reach a better understanding of vaccines mechanism of action and to improve the tolerance and acceptability of vaccines and additives. The ageing of the populations and the increase of subjects at risk also require to improve the immunogenicity and the efficiency of existing vaccines. The constant emergence of new epidemics or the development of the antibio-resistance imposes innovation and development of new vaccines. The recent difficulties faced by the development of vaccines against malaria, tuberculosis or AIDS illustrate the necessity of moving beyond classical recipes and of elaborating new vectors and new adjuvants, of better understanding the heterogeneity of vaccine immunity and of developing alternative routes of immunization. Multidisciplinary researches using the most recent advances in molecular, structural and cellular biology, in microbiology, immunology and of genetic engineering to answer these worldwide challenges.

Identifiers

PMID32226055
PMCPMC7095193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.